Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML
2018 · Leukemia · 311 citations
https://doi.org/10.1038/s41375-018-0180-3
F
Felix S. Lichtenegger
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
55
Papers
1.9K
Citations
21
h-index
23
i10-index
Felix S. Lichtenegger is an academic researcher from Urologische Klinik München. The author has contributed to research in topics: CAR-T cell therapy research & Immune Cell Function and Interaction & Immunotherapy and Immune Responses. The author has an h-index of 21, co-authored 47 publications.
ORCID: 0000-0003-3990-1802Papers by this author
worksNeutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours
2024 · Nature · 75 citations
https://doi.org/10.1038/s41586-024-08305-z
RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade
2019 · Leukemia · 46 citations
https://doi.org/10.1038/s41375-019-0639-x
Effects of TLR agonists on maturation and function of 3-day dendritic cells from AML patients in complete remission
2011 · Journal of Translational Medicine · 40 citations
https://doi.org/10.1186/1479-5876-9-151
LBA110 A blinded, exploratory phase II trial of nivolumab and the GDF-15 neutralizing antibody visugromab or placebo as neoadjuvant treatment of patients with muscle-invasive bladder cancer (MIBC): Primary results of the GDFather-NEO trial
2025 · Annals of Oncology · 1 citations
https://doi.org/10.1016/j.annonc.2025.09.129
1513O Long-term follow-up GDFATHER-01 trial: GDF-15 neutralization combined with nivolumab can enable deep, long-term remission in heavily pretreated, anti-PD1/-L1 relapsed/refractory non-squamous non-small cell lung cancer (NSCLC), urothelial cancer (UC) and hepatocellular cancer (HCC)
2025 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2025.08.2144
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat